Navidea biopharmaceuticals, inc. hires g2g ventures as executive consultants; chief medical officer steps down

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announces the company has hired g2g ventures (g2g) as executive consultants to provide executive team support for navidea's aggressive growth plans. separately, michael rosol, ph.d., has stepped down as chief medical officer for the company.
NAVB Ratings Summary
NAVB Quant Ranking